Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals
Ironwood Pharmaceuticals Inc’s recently made public that its SVP, Chief Business Officer Davis Andrew unloaded Company’s shares for reported $21869.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Ironwood Pharmaceuticals Inc’s recent filing unveils that its SVP, Chief Business Officer Davis Andrew unloaded Company’s shares for reported $21869.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals
Ironwood Pharmaceuticals Inc’s recently made public that its SVP, Chief Business Officer Davis Andrew unloaded Company’s shares for reported $21869.0
Ironwood Pharmaceuticals Inc’s recently made public that its SVP, Chief Business Officer Davis Andrew unloaded Company’s shares for reported $21869.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Ironwood Pharmaceuticals Inc revealed its Officer Davis Andrew acquired Company’s shares for reported $25030.0 on Nov 18
In a filing, Ironwood Pharmaceuticals Inc revealed its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on
